{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:53:47Z","timestamp":1762001627238,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1053\/j.seminhematol.2006.04.008","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T13:47:14Z","timestamp":1151675234000},"page":"S11-S17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S5","title":["Recent Advances in the Treatment of Childhood Immune Thrombocytopenic Purpura"],"prefix":"10.1053","volume":"43","author":[{"given":"Michael","family":"Tarantino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2006.04.008_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ajh.10432","article-title":"Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura","volume":"74","author":"Chun","year":"2003","journal-title":"Am J Hematol"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2006.04.008_bib2","first-page":"299a","article-title":"High-dose anti-D immune globulin is as effective as IVIg in the treatment of newly diagnosed immune thrombocytopenic purpura (ITP) in children","volume":"102","author":"Tarantino","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib3","series-title":"Hematology of Infancy and Childhood","first-page":"1585","article-title":"Platelet abnormalities in infancy and childhood","author":"Beardsley","year":"1988"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(95)90471-9","article-title":"A new method for active surveillance of adverse events from diphtheria\/tetanus\/pertussis and measles\/mumps\/rubella vaccines","volume":"345","author":"Farrington","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archpedi.152.4.345","article-title":"Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia?","volume":"152","author":"Calpin","year":"1998","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2141.1999.01218.x","article-title":"A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura","volume":"104","author":"Warner","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V71.4.1165.1165","article-title":"Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP)","volume":"71","author":"Bellucci","year":"1988","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00043426-198424000-00001","article-title":"Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial","volume":"6","author":"Buchanan","year":"1984","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00043426-198406020-00008","article-title":"Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study","volume":"6","author":"Sartorius","year":"1984","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3476(05)80400-7","article-title":"A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura","volume":"123","author":"Blanchette","year":"1993","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)92205-5","article-title":"Randomised trial of intravenous immune globulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura","volume":"344","author":"Blanchette","year":"1994","journal-title":"Lancet"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2006.04.008_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1651-2227.1998.tb01239.x","article-title":"Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP)","volume":"424","author":"Carcao","year":"1998","journal-title":"Acta Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0022-3476(05)82024-4","article-title":"Acute immune thrombocytopenic purpura","volume":"125","author":"Albayrak","year":"1994","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00043426-200210000-00008","article-title":"Randomized trial of high-dose methylprednisolone versus intravenous immune globulin for the treatment of acute idiopathic thrombocytopenic purpura in children","volume":"24","author":"Ancona","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-3476(88)80654-1","article-title":"Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura","volume":"113","author":"van Hoff","year":"1988","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00043426-199705000-00004","article-title":"Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura","volume":"19","author":"Warrier","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00043426-200310000-00011","article-title":"Low-dose versus high-dose immune globulin for primary treatment of acute immune thrombocytopenic purpura in children","volume":"25","author":"Benesch","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib20","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V89.8.2689","article-title":"Intravenous anti-D treatment of immune thrombocytopenic purpura","volume":"89","author":"Scaradavou","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-3476(99)70367-7","article-title":"Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin","volume":"134","author":"Tarantino","year":"1999","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib22","first-page":"887","article-title":"Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura","volume":"85","author":"Monteleone","year":"2000","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib23","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2141.2001.02627.x","article-title":"A dose of 75 microg\/kg\/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg\/kg\/d in adults with immune thrombocytopenic purpura","volume":"112","author":"Newman","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.hoc.2004.07.003","article-title":"The pros and cons of drug therapy for immune thrombocytopenic purpura in children","volume":"18","author":"Tarantino","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00319963","article-title":"Interim evaluation of two cooperative studies assessing the effects of intravenous immunoglobulin (i.v. IgG) on childhood idiopathic thrombocytopenic purpura (ITP)","volume":"48","author":"Imbach","year":"1984","journal-title":"Blut"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/08880010252899370","article-title":"Clinical course of children with immune thrombocytopenic purpura treated with intravenous immune globulin G or megadose methylprednisolone or observed without therapy","volume":"19","author":"Duru","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpeds.2005.04.032","article-title":"Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children","volume":"147","author":"Beck","year":"2005","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00043426-200308000-00017","article-title":"Intracranial hemorrhage in immune thrombocytopenic purpura","volume":"25","author":"Butros","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1054\/blre.2001.0186","article-title":"Pharmacoeconomics of therapy for ITP","volume":"16","author":"Adams","year":"2002","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0022-3476(98)70265-3","article-title":"Major hemorrhage in children with idiopathic thrombocytopenic purpura","volume":"133","author":"Medeiros","year":"1998","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1067\/mpd.2000.110123","article-title":"The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immune globulins or sustained prednisone treatment","volume":"137","author":"Dickerhoff","year":"2000","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib32","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(01)07219-1","article-title":"Newly diagnosed idiopathic thrombocytopenic purpura in childhood","volume":"358","author":"Kuhne","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib33","first-page":"518","article-title":"Renal insufficiency and failure associated with immune globulin intravenous therapy\u2014United States, 1985-1998","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl 2","key":"10.1053\/j.seminhematol.2006.04.008_bib34","first-page":"35","article-title":"Adverse reactions after high-dose intravenous immune globulin","volume":"78","author":"Schiavotto","year":"1993","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1468-1331.2003.00542.x","article-title":"Thrombosis complicating high dose intravenous immune globulin","volume":"10","author":"Zaidan","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib36","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/bmj.324.7345.1056","article-title":"Intravenous immune globulin increases risk of thrombotic events","volume":"324","author":"Gottlieb","year":"2002","journal-title":"BMJ"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib37","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V95.8.2523","article-title":"Acute onset hemoglobinemia and\/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients","volume":"95","author":"Gaines","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib38","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2004-11-4303","article-title":"Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura","volume":"106","author":"Gaines","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/000992280104000114","article-title":"Severe acute renal failure due to hemoglobinuria after use of WinRho for the treatment of idiopathic thrombocytopenic purpura","volume":"40","author":"Roberti","year":"2001","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00467-001-0763-4","article-title":"Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura","volume":"17","author":"Kees-Folts","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib41","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00043426-200110000-00014","article-title":"Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia","volume":"23","author":"Levendoglu-Tugal","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib43","series-title":"Leitlinien Kenderheilkunde und Jugenmedizin","first-page":"23","article-title":"H\u00e4mostasiologie","author":"Sutor","year":"1999"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib44","first-page":"295","article-title":"A randomized and comparative study of intravenous immune globulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura","volume":"45","author":"Erduran","year":"2003","journal-title":"Turk J Pediatr"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1365-2141.2001.02807.x","article-title":"Early Chronic ITP Study Group: Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: A pilot study","volume":"113","author":"Foster","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2004.05235.x","article-title":"Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood","volume":"127","author":"Bruin","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2006.04.008_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2141.2003.04033.x","article-title":"Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura","volume":"120","author":"Carcao","year":"2003","journal-title":"Br J Haematol"},{"year":"2005","series-title":"FCGR3A genotype affects the platelet response to immune globulin (Ig) treatment of acute immune thrombocytopenic purpura (ITP) in children","author":"Tarantino","key":"10.1053\/j.seminhematol.2006.04.008_bib48"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196306000904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196306000904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:16:38Z","timestamp":1758521798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196306000904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":48,"alternative-id":["S0037196306000904"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2006.04.008","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in the Treatment of Childhood Immune Thrombocytopenic Purpura","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2006.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}